T cell receptor beta variable 6-4 (TRBV6-4)

T cell receptor beta variable 6-4 (TRBV6-4) is a protein-coding gene encoding the V region of the variable domain of the T cell receptor (TCR) beta chain[1][3][7]. This region participates in antigen recognition by forming part of the antigen-binding site of the TCR complex on T lymphocytes. Alpha-beta TCRs, formed by α and β chains, are essential for adaptive immunity, as they specifically recognize peptide-major histocompatibility (pMH) complexes displayed by antigen-presenting cells. The TCR variable regions, generated through V(D)J recombination during T cell development, provide immense diversity for antigen specificity, critical for recognizing a broad array of pathogens and maintaining self-tolerance[1][2]. Signaling downstream of TCR engagement initiates T cell activation, proliferation, and effector function, playing a central role in immune defense, immunological memory, and—in some contexts—autoimmunity or tumor immunity[2][5][6]. \nTRBV6-4 represents one of many variable gene segments in the human TCR beta locus and is key to overall TCR diversity but is not itself a unique therapeutic target.

Other names

TCRBV13S5TCRBV6S4TRBV64V segment translation product

Not directly drug-targeted; however, modulation of the T cell receptor (TCR) signaling pathway—including the TCR-CD3 complex—forms the basis of various immunotherapies (e.g., immune checkpoint inhibitors, CAR T cells), typically involving downstream signaling molecules rather than this variable segment specifically[4][5].